Teveten (eprosartan), a new angiotensin II receptor blocker (ARB)

January 2001

Solvay is now marketing Teveten (eprosartan), a new angiotensin II receptor blocker (ARB).

Teveten will be used for mild to moderate hypertension...alone or in combination with a diuretic.

ARBs work as well as ACE inhibitors for hypertension. Plus they're better tolerated...less cough, angioedema, etc.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology Teveten (eprosartan), a new angiotensin II receptor blocker (ARB)
Cardiology Diovan for heart failure
Gastroenterology new option for bowel cleansing prior to a colonoscopy called Visicol
Iron new injectable forms of iron
3TC (lamivudine) is now approved for HIV/AIDS in children
getting HIV patients to take at least 95% of their antiretroviral meds on time
Enbrel, a new drug for rheumatoid arthritis
IBS treating irritable bowel syndrome
Infectious Diseases Typherix, a new IM vaccine for typhoid fever
Infectious Diseases the trend to write "if-needed" antibiotic Rxs
Some physicians in the U.S. will start getting samples of GENERICS
Supplements using NADH for jet lag
more physicians treat migraines in teenagers with triptans